Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.36%
1,096.72
+3.98
+0.36%
—1,092.741,095.951,103.321,094.72——
SIXC
Communications
SIXC
Communications
SIXC
-0.33%
611.32
-2.04
-0.33%
—613.36613.36613.36609.50——
SIXE
Energy
SIXE
Energy
SIXE
-0.45%
1,171.54
-5.25
-0.45%
—1,176.791,176.521,182.251,166.69——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.45%
1,747.63
-7.91
-0.45%
—1,755.541,759.231,766.301,746.04——
SIXM
Financials
SIXM
Financials
SIXM
-0.58%
631.49
-3.66
-0.58%
—635.15635.20636.89630.09——
SIXR
Staples
SIXR
Staples
SIXR
+0.23%
849.94
+1.93
+0.23%
—848.01852.52855.78849.58——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0.09%
218.06
+0.20
+0.09%
—217.86217.86219.52217.86——
SIXT
Technology
SIXT
Technology
SIXT
+3.47%
3,536.03
+118.68
+3.47%
—3,417.353,452.773,536.033,450.39——
SIXU
Utilities
SIXU
Utilities
SIXU
-0.91%
905.07
-8.29
-0.91%
—913.36915.10920.43904.57——
SIXV
Health care
SIXV
Health care
SIXV
-0.86%
1,449.86
-12.52
-0.86%
—1,462.381,461.131,464.531,446.02——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.30%
2,430.47
+7.33
+0.30%
—2,423.142,428.712,448.692,424.63——
BH3:FRA
PTC Therapeutics, Inc.
€61.66
+8.86%
(+5.02) 1D
May 11, 8:12:17 AM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for BH3...
Open
€61.66
High
€61.66
Low
€61.66
Mkt. cap
6.11B
Avg. vol.
0.00
Volume
0.00
52-wk high
€75.00
52-wk low
€36.00
No. of employees
991
News stories
From sources across the web
Profile
PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control mechanisms in orphan diseases. In September 2009, PTC entered into an agreement with Roche for the development of orally bioavailable small molecules for central nervous system diseases. PTC acquired the Bio-e platform in 2019. Wikipedia
About PTC Therapeutics, Inc.
CEOMatthew B. Klein
Employees991
FoundedJan 1, 1998
HeadquartersWarren, New Jersey, United States
SectorBiotechnology
Websiteptcbio.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
178.88M
211.01M
164.68M
272.55M
Cost of goods sold
124.41M
115.94M
140.08M
128.90M
Cost of revenue
124.41M
115.94M
140.08M
128.90M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
85.26M
84.05M
96.87M
86.18M
Operating expense
89.32M
91.58M
106.22M
97.76M
Total operating expenses
213.73M
207.52M
246.30M
226.66M
Operating income
-34.86M
3.49M
-81.62M
45.89M
Other non operating income
2.96M
102.00K
-7.65M
1.61M
EBT including unusual items
-71.05M
-23.07M
-139.08M
-2.46M
EBT excluding unusual items
-70.95M
-31.40M
-150.16M
-1.54M
Income tax expense
-6.20M
-38.97M
-4.12M
347.00K
Effective tax rate
8.73%
168.89%
2.96%
-14.09%
Other operating expenses
-
-
-
-
Net income
-64.85M
15.90M
-134.96M
-2.81M
Net profit margin
-36.25%
7.53%
-81.96%
-1.03%
Earnings per share
-0.83
0.19
-1.80
-0.03
Interest and investment income
20.99M
19.09M
2.14M
-
Interest expense
-51.35M
-51.68M
-57.32M
-49.03M
Net interest expenses
-30.36M
-32.59M
-55.19M
-49.03M
Depreciation and amortization charges
-
-
-
-
EBITDA
-27.28M
14.60M
-68.72M
55.59M
Gain or loss from assets sale
-
53.00K
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer